Bell Potter says this ASX 200 share can rise 50%

The broker thinks this stock is being seriously undervalued by the market.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Bell Potter sees significant upside in Nufarm shares, citing strong FY26 EBITDA growth potential and improved debt positions as key factors.
  • Nufarm's FY25 results met expectations, with a focus on growth in crop protection and seed technologies, poised for continued momentum in FY26.
  • Bell Potter has issued a buy rating with a $3.60 price target, suggesting a potential 52% return over the next year, alongside expected dividend yields growing to 3% by FY28.

Nufarm Ltd (ASX: NUF) shares could be an ASX 200 share to buy right now.

That's the view of analysts at Bell Potter, which see significant upside potential for the agricultural company's shares.

A man clenches his fists in excitement as gold coins fall from the sky.

Image source: Getty Images

What is the broker saying about this ASX 200 share?

Bell Potter highlights that Nufarm released its results this week and delivered numbers that were in line with expectations and its guidance. It said:

Revenue of $3,443m was up +3% YOY (vs. BPe $3,464m). Operating EBITDA of $302.1m was up down -3% YOY (BPe $302.5m and implied guidance of $283-308m). Operating NPAT loss of -$22.9m compares to a -$3.7m loss in FY24 (and vs. BPe -$9.4m). Hybrid Seeds generated EBITDA of $67m (vs. $74m FY24) and the emerging seed platforms incurred a loss of -$53m (-$11m loss in FY24) inclusive of $29m in inventory impairments and ~$20m in operating losses in omega-3.

It was also pleased to see that Nufarm's debt had reduced to $824.2 million at the end of FY 2025, which was better than its guidance of $850 million to $925 million.

Looking ahead, the broker points out that management is guiding to EBITDA growth in FY 2026.

Key comments: (1) Expect strong FY26e underlying EBITDA growth under normal conditions; (2) Crop protection EBITDA continuing to grow, moderating on the +18% YOY growth in FY25; (2) Seed technologies growth in EBITDA from hybrid Seed and targeting a $30m YOY improvement in the emerging platforms; and (4) Expect positive free cashflow in FY26e and net debt/EBITDA of ~2.0x (vs. 2.7x in FY25).

Big return potential

In response to the results, Bell Potter has retained its buy rating on the ASX 200 share with an improved price target of $3.60.

Based on the current Nufarm share price of $2.37, this implies potential upside of 52% for investors over the next 12 months.

To put that into context, a $10,000 investment would turn into over $15,000 by this time next year if Bell Potter is on the money with its recommendation.

In addition, the broker is expecting a modest 1.3% dividend yield in FY 2026, and then 2.1% in FY 2027 and 3% in FY 2028.

Commenting on its buy recommendation, Bell Potter said:

NUF delivered a FY25 result modestly ahead of consensus, driven by +170bp topline outperformance in Crop protection revenue growth (relative to sector aggregates) and highlighted by a better-than-expected net debt position. In recent weeks we have witnessed a strengthening in omega-3 oil pricing indicators (following the IMARPE catch quota) while also noting continued YOY growth in active ingredient values.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Top ten gold trophy.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors weren't in a good mood this Tuesday.

Read more »

A child covering his eyes hiding from a toy bear.
Broker Notes

Brokers rate these 5 ASX 200 shares as a sell!

Find out why brokers are so bearish about these ASX 200 shares.

Read more »

a woman looks exhausted and overwhelmed as she slumps forward into her hand while looking at her laptop screen.
52-Week Lows

Are CSL and ResMed shares buys at 52-week lows?

These ASX healthcare shares may not regain investor confidence overnight, but I think they are worth studying while sentiment is…

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

WiseTech, Cochlear, CSL shares: Can these beaten down stocks rebound in 2026?

It looks like brokers have lost confidence in one of these shares.

Read more »

A woman looks at a tablet device while in the aisles of a hardware style store amid stacked boxes on shelves representing Bunnings and the Wesfarmers share price
Broker Notes

Wesfarmers shares: Buy, hold or sell?

Two leading analysts offer their outlooks for Wesfarmers shares.

Read more »

A young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
52-Week Highs

3 top ASX shares at 52-week highs I'd still buy

A 52-week high should not automatically scare investors away if the business still has room to improve over time.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Share Gainers

Why DroneShield, Pro Medicus, SRG Global, and Woodside shares are charging higher today

These shares are avoiding the market weakness and charging higher on Tuesday.

Read more »

Three young people in business attire sit around a desk and discuss.
Broker Notes

Buy, hold, sell: Origin Energy, Megaport, NAB shares

We review three new buy, hold, and sell calls from expert market analysts.

Read more »